Henry Schein, Inc. logo

Henry Schein, Inc. (HS2)

Market Closed
17 Jul, 20:00
XDUS XDUS
76. 00
-0.5
-0.6536%
- Market Cap
21.94 P/E Ratio
- Div Yield
0 Volume
4.54 Eps
76.5
Previous Close
Add Transaction
Day Range
74.5 77
Year Range
52.06 77.5
Want to track HS2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HS2 closed yesterday lower at €76, a decrease of -0.6536% from Thursday's close, completing a monthly increase of 5.5556% or €4. Over the past 12 months, HS2 stock gained 18.5278%.
HS2 is not paying dividends to its shareholders.
The last earnings report, released on May 04, 2026, missed the consensus estimates by -1.21%. On average, the company has fell short of earnings expectations by -0.8367%, based on the last three reports.
Henry Schein, Inc. has completed 1 stock splits, with the recent split occurring on Sep 15, 2017.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

HS2 Chart

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 week ago
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 weeks ago
Henry Schein: Smile Because The Upside Isn't Over

Henry Schein: Smile Because The Upside Isn't Over

Henry Schein remains a dominant global provider in dental and medical practitioner supplies, with strong market shares and ongoing revenue growth. HSIC's Q1 2026 revenue grew 6.3% year-over-year, driven by robust global dental merchandise and equipment demand, particularly in aging and expanding populations. Profitability metrics are mixed, but adjusted net income and EBITDA are rising; management guides for 3–5% revenue growth and mid-single-digit EBITDA growth in 2026.

Seekingalpha | 3 weeks ago

Henry Schein, Inc. (HS2) FAQ

What is the stock price today?

The current price is €76.00.

On which exchange is it traded?

Henry Schein, Inc. is listed on XDUS.

What is its stock symbol?

The ticker symbol is HS2.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Henry Schein, Inc. ever had a stock split?

Henry Schein, Inc. had 1 splits and the recent split was on Sep 15, 2017.

Henry Schein, Inc. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Mr. Ronald N. South CEO
XDUS Exchange
US8064071025 ISIN
BR Country
25,000 Employees
- Last Dividend
8 Feb 2019 Last Split
3 Nov 1995 IPO Date

Overview

Henry Schein, Inc. stands as a pivotal provider of healthcare products and services tailored for dental practitioners, laboratories, physician practices, and ambulatory surgery centers. It also extends its offerings to government and institutional health care clinics, and various alternate care clinics globally. Founded in 1932, with its headquarters nestled in Melville, New York, Henry Schein operates through two principal segments: Health Care Distribution, and Technology and Value-Added Services. The company's vast reach and diverse portfolio allow it to be an influential player in promoting wellness and efficiency across the healthcare landscape.

Products and Services

  • Health Care Distribution

    This segment delivers an extensive range of dental products including essential infection-control products, handpieces, preventatives, and materials for impressions and restorations. It encompasses everything from anesthetics, teeth, and implants, to advanced dental equipment such as chairs, delivery units, lights, and X-ray supplies. Moreover, the division offers pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins, catering not just to dental, but also medical needs. Noteworthy is its inclusion of personal protective equipment and services for equipment repair, highlighting its commitment to safety and reliability in healthcare supplies.

  • Technology and Value-Added Services

    This segment is dedicated to enhancing healthcare practices through innovative software, technology solutions, and supplementary services. It features practice management software systems designed for dental and medical practitioners, aiming to streamline workflows and improve operational efficiency. Further amplifying its value proposition, Henry Schein provides a suite of value-added practice solutions. These encompass consultancy services, education, revenue cycle management, financial services, e-services, and support for practice technology. Also available are network and hardware services, consulting, and continuing education services. This multifaceted approach helps practitioners focus on patient care while optimizing their practice's performance and profitability.

Contact Information

Address: 135 Duryea Road, Melville, NY, United States, 11747
Phone: 631 843 5500